Deciphera Pharmaceuticals, Inc.
NASDAQ: DCPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Steven L. Hoerter
- Employees
- 355
- Headquarters
- Waltham, United States
- IPO year
- 2017
- Market cap
- $2.2B
- Website
- https://www.deciphera.com
Loading DCPH…
Loading profile data…Frequently asked questions about DCPH
What does Deciphera Pharmaceuticals, Inc. (DCPH) do?
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical firm focused on developing innovative therapies to significantly improve outcomes for cancer patients. Their core strategy involves tackling the mechanisms of drug resistance that often limit the effectiveness and longevity of current cancer treatments, serving markets both domestically and...
Where does DCPH trade?
Deciphera Pharmaceuticals, Inc. (DCPH) trades on the NASDAQ Global Select.
What sector is DCPH in?
Deciphera Pharmaceuticals, Inc. (DCPH) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Deciphera Pharmaceuticals, Inc.?
Steven L. Hoerter is the chief executive officer of Deciphera Pharmaceuticals, Inc. (DCPH).
Where is Deciphera Pharmaceuticals, Inc. headquartered?
Deciphera Pharmaceuticals, Inc. is headquartered in United States.
Does DCPH pay a dividend?
Deciphera Pharmaceuticals, Inc. (DCPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DCPH go public?
Deciphera Pharmaceuticals, Inc. (DCPH) completed its initial public offering in 2017.